Australia maps knee and hip replacement costs in Aus$4bn musculoskeletal bill
This article was originally published in Clinica
Spending on arthritis and musculoskeletal care has grown by more than 5% between 2000-01 and 2004-05, when it was the fourth-largest contributor to overall healthcare spending, accounting for Aus$4bn (US$3.7bn) or 7% of the total budget. So highlights the Australian Institute of Health and Welfare (AIHW) from its report Health expenditure for arthritis and musculoskeletal conditions 2004-05. Osteoarthritis alone accounted for almost a third of spending across this area of care, and 75% of this went on hospital costs related mainly to knee and hip replacements.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.